Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

Aikili Biosystems Inc — Funding, Investors & Profile — Capbase

← All companies

Compare History

Aikili Biosystems Inc

Private

Won 2 federal SBIR/STTR research awards from HHS and other federal agencies.

Department of Health and Human ServicesNational Institutes of Health

SAM UEI: HF3BL8RZ1WJ1

Founded: —Source: [GOV]
Headquarters: Cambridge, MassachusettsSource: [GOV]
Headcount: 2Source: [GOV]
Stage: Seed
Sector: Healthcare

$0Source: [GOV]Total raised

UndisclosedSource: [GOV]Last valuation

Overview

Aikili Biosystems Inc has been awarded 2 US Small Business Innovation Research (SBIR/STTR) contracts totalling $800,000 in 2021. These are non-dilutive federal research grants, not equity financing. The company is based in Cambridge, Massachusetts.

Funding rounds

2 rounds

SBIR Phase I award (HHS)GrantMar 2021Source: [GOV]
$400K
—post-money
SBIR Phase I award (HHS)

Investors

No investors recorded yet for Aikili Biosystems Inc.

Add an investor

People

Leadership

LAURA E KELLEYPrincipal investigatorSince 2021Source: [GOV]

Acquisitions

Aikili Biosystems Inc has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Record an exit

Diversity investments

No diversity signals recorded yet for Aikili Biosystems Inc.

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.

Grant

Aug 2021Source: [GOV]

$400K

—post-money